Inhibitory effect of novel Eugenol Tosylate Congeners on pathogenicity of Candida albicans

BACKGROUND: The global prevalence of fungal diseases is increasing rapidly, which affects more than a billion people every year with significant mortality rate. On the other hand, the development of new drugs to treat these fungal infections is slow, while the current antifungal therapy is insuffici...

Descripción completa

Detalles Bibliográficos
Autores principales: Lone, Shabir Ahmad, Ahmad, Aijaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191809/
https://www.ncbi.nlm.nih.gov/pubmed/32349730
http://dx.doi.org/10.1186/s12906-020-02929-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191809/
https://www.ncbi.nlm.nih.gov/pubmed/32349730
http://dx.doi.org/10.1186/s12906-020-02929-0

Ejemplares similares